| Abstrakt: |
A recent study conducted by researchers at Prince of Songkla University in Thailand aimed to evaluate the effectiveness of the aMAP score in predicting the development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). The study analyzed data from 789 eligible patients with CHB, of whom 51 developed HCC. The results showed that the aMAP score, based on age, sex, albumin-bilirubin level, and platelet count, was a valuable tool for predicting HCC risk in Thai patients with CHB. However, the performance of the aMAP score was found to be inferior to that of the CU-HCC score, suggesting the need for new predictive tools for HCC surveillance. [Extracted from the article] |
